Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 10 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 7 8 9 10 presentations: 1 to 50 of 454
ORAL ABSTRACT: CRITICAL ISSUES IN WOMEN'S HEALTH, MTCT, AND HIV TREATMENT IN CHILDREN
RANDOMIZED TRIAL OF LEEP VS CRYOTHERAPY TO TREAT CIN2/3 IN HIV-INFECTED WOMEN
Sharon A Greene
University of Washington, Seattle, WA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN WOMEN'S HEALTH, MTCT, AND HIV TREATMENT IN CHILDREN
NATURAL HISTORY OF CERVICAL INTRAEPITHELIAL NEOPLASIA-2 AMONG HIV-INFECTED WOMEN
Kate Michel
Georgetown University, Washington, DC, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN WOMEN'S HEALTH, MTCT, AND HIV TREATMENT IN CHILDREN
INTEGRATION OF POSTNATAL SERVICES IMPROVES MCH AND ART OUTCOMES: A RANDOMISED TRIAL
Landon Myer
University of Cape Town, Cape Town, South Africa
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN WOMEN'S HEALTH, MTCT, AND HIV TREATMENT IN CHILDREN
ADVERSE BIRTH OUTCOMES DIFFER BY ART REGIMEN FROM CONCEPTION IN BOTSWANA
Rebecca Zash
Beth Israel Deaconess Medical Center, Boston, MA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN WOMEN'S HEALTH, MTCT, AND HIV TREATMENT IN CHILDREN
EFFECT OF POINT-OF-CARE TESTING ON ANTIRETROVIRAL-THERAPY INITIATION RATES IN INFANTS
Ilesh Jani
Instituto Nacional de Saude, Maputo, Mozambique
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN WOMEN'S HEALTH, MTCT, AND HIV TREATMENT IN CHILDREN
TREATMENT OF ACUTE HIV INFECTION IN NEONATES
Louise Kuhn
Columbia University, New York, NY, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN WOMEN'S HEALTH, MTCT, AND HIV TREATMENT IN CHILDREN
RAPID DECLINE OF TOTAL HIV DNA IN CHILDREN STARTING ART WITHIN 8 DAYS OF BIRTH
Kirsten Abigail Veldsman
Stellenbosch University, Parow, South Africa
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN WOMEN'S HEALTH, MTCT, AND HIV TREATMENT IN CHILDREN
LOPINAVIR/RITONAVIR 1:1 SUPER-BOOSTING OVERCOMES RIFAMPICIN INTERACTIONS IN CHILDREN
Helena Rabie
University of Stellenbosch, Cape Town, South Africa
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: GETTING HIV THROUGH THE CELL
QUATERNARY CONFIGURATION OF THE FUNCTIONAL CD4-BINDING SITE IN THE HIV-1 ENV TRIMER
Qingbo Liu
NIH, Bethesda, MD, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: GETTING HIV THROUGH THE CELL
EARLY CYTOPLASMIC UNCOATING IS NECESSARY FOR INFECTIVITY OF HIV-1
João I Mamede
Northwestern University, Chicago, IL, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: GETTING HIV THROUGH THE CELL
ECCENTRIC VIRAL GENOMIC RNA AND INTEGRASE ARE PREMATURELY DEGRADED IN TARGET CELLS
Sebla B Kutluay
Washington University in St. Louis, St. Louis, MO, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: GETTING HIV THROUGH THE CELL
DYNAMICS OF NUCLEAR ENVELOPE ASSOCIATION AND NUCLEAR IMPORT OF HIV-1 COMPLEXES
Ryan C Burdick
National Cancer Institute, Frederick, MD, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: GETTING HIV THROUGH THE CELL
CYPA REGULATES HIV-1 ACCESS TO AN FG-GUIDED NUCLEAR ENTRY PATHWAY
Guangai Xue
National Cancer Institute, Frederick , MD, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: GETTING HIV THROUGH THE CELL
A COMPREHENSIVE CRISPR SCREEN IDENTIFIES NOVEL HIV RESTRICTION FACTORS
Molly Ohainle
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: GETTING HIV THROUGH THE CELL
A RETROTRANSPOSED ESCRT-III FACTOR BLOCKS HIV-1 BUDDING WITHOUT INDUCING CYTOTOXICITY
Lara Rheinemann
University of Utah, Salt Lake City, UT, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: GETTING HIV THROUGH THE CELL
DESIGNED PROTEINS INDUCE THE FORMATION OF NANOCAGE-CONTAINING EXTRACELLULAR VESICLES
Joerg Votteler
University of Utah, Salt Lake City, UT, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIDING IN PLAIN SIGHT: DISCOVERING THE UNDIAGNOSED AND UNDERTREATED HIV EPIDEMIC
HIV INCIDENCE, PREVALENCE, AND UNDIAGNOSED INFECTIONS IN MEN WHO HAVE SEX WITH MEN
Sonia Singh
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIDING IN PLAIN SIGHT: DISCOVERING THE UNDIAGNOSED AND UNDERTREATED HIV EPIDEMIC
VIRAL-LOAD DYNAMICS AMONG PERSONS WITH DIAGNOSED HIV: UNITED STATES, 2014
Nicole Crepaz
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIDING IN PLAIN SIGHT: DISCOVERING THE UNDIAGNOSED AND UNDERTREATED HIV EPIDEMIC
TIME SPENT WITH HIV VIRAL LOAD >1500 COPIES/mL AMONG PATIENTS IN HIV CARE, 2000-2014
Kate Buchacz
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIDING IN PLAIN SIGHT: DISCOVERING THE UNDIAGNOSED AND UNDERTREATED HIV EPIDEMIC
A RANDOMIZED TRIAL OF NOVEL STRATEGIES TO INCENTIVIZE HIV TESTING AMONG MEN IN UGANDA
Gabriel Chamie
University of California, San Francisco, San Francisco, CA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIDING IN PLAIN SIGHT: DISCOVERING THE UNDIAGNOSED AND UNDERTREATED HIV EPIDEMIC
COMBINATION HIV PREVENTION AND HIV INCIDENCE IN RAKAI, UGANDA
Mary K Grabowski
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIDING IN PLAIN SIGHT: DISCOVERING THE UNDIAGNOSED AND UNDERTREATED HIV EPIDEMIC
NAMIBIA PILOTS SENTINEL POPULATION SURVEILLANCE OF HIV INCIDENCE AND VIRAL SUPRESSION
Sadhna V Patel
U.S. Centers for Disease Control and Prevention, Atlanta, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIDING IN PLAIN SIGHT: DISCOVERING THE UNDIAGNOSED AND UNDERTREATED HIV EPIDEMIC
SOCIAL NETWORKS AND HIV PREVALENCE IN KENYA IN THE SEARCH STUDY
Wenjing Zheng
University of California, Berkeley, Berkeley, CA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIDING IN PLAIN SIGHT: DISCOVERING THE UNDIAGNOSED AND UNDERTREATED HIV EPIDEMIC
HIGH RATE OF DISEASE PROGRESSION IN UNTREATED HIV-2 INFECTION
Joakim Esbjörnsson
University of Oxford, Oxford, United Kingdom
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: NEW HIV DRUGS, FORMULATIONS, COMBINATIONS, AND RESISTANCE
DISCOVERY OF NOVEL POTENT HIV CAPSID INHIBITORS WITH LONG-ACTING POTENTIAL
Winston C Tse
Gilead Sciences, Foster City, CA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: NEW HIV DRUGS, FORMULATIONS, COMBINATIONS, AND RESISTANCE
HUMAN CONFIRMATION OF ORAL DOSE REDUCTION POTENTIAL OF NANOPARTICLE ARV FORMULATIONS
Andrew Owen
University of Liverpool, Liverpool, Merseyside, United Kingdom
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: NEW HIV DRUGS, FORMULATIONS, COMBINATIONS, AND RESISTANCE
CLINICAL PHARMACOLOGY OF THE HIV INTEGRASE STRAND TRANSFER INHIBITOR BICTEGRAVIR
Joseph M. Custodio
Gilead Science, Foster city, CA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: NEW HIV DRUGS, FORMULATIONS, COMBINATIONS, AND RESISTANCE
RANDOMIZED TRIAL OF BICTEGRAVIR OR DOLUTEGRAVIR WITH FTC/TAF FOR INITIAL HIV THERAPY
Paul E Sax
Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: NEW HIV DRUGS, FORMULATIONS, COMBINATIONS, AND RESISTANCE
PATHWAYS OF RESISTANCE IN SUBJECTS FAILING DOLUTEGRAVIR MONOTHERAPY
José L Blanco
Hospital Clinic, Barcelona, Outside USA or Canada, Spain
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: NEW HIV DRUGS, FORMULATIONS, COMBINATIONS, AND RESISTANCE
PREVALENCE AND IMPACT OF PRETREATMENT DRUG RESISTANCE IN THE ANRS 12249 TASP TRIAL
Anne Derache
Africa Health Research Institute, Mtubatuba, South Africa
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: NEW HIV DRUGS, FORMULATIONS, COMBINATIONS, AND RESISTANCE
PHASE III SWORD 1&2: SWITCH TO DTG+RPV MAINTAINS VIROLOGIC SUPPRESSION THROUGH 48 WKS
Josep M Llibre
Univ Hosp Germans Trias, Badalona, Barcelona, Spain
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: NEW HIV DRUGS, FORMULATIONS, COMBINATIONS, AND RESISTANCE
DORAVIRINE IS NON-INFERIOR TO DARUNAVIR/R IN PHASE 3 TREATMENT-NAÏVE TRIAL AT WEEK 48
Kathleen Squires
Thomas Jefferson University, Philadelphia, PA, USA
from CROI 2017 on February 14, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CNS RESERVOIRS, NEUROPATHOGENESIS, AND HOST FACTORS
INTENSITY OF SUPPRESSION LINKED WITH SHIFTING COMPARTMENTALIZATION OF CNS HIV DNA
Benjamin B Gelman
University of Texas Medical Branch , Galveston, TX, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CNS RESERVOIRS, NEUROPATHOGENESIS, AND HOST FACTORS
CNS PARENCHYMA AND CHOROID PLEXUS, NOT CSF, ARE VIRAL RESERVOIRS IN MONKEYS WITH AIDS
Jaclyn Mallard
Boston College, Chestnut Hill, MA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CNS RESERVOIRS, NEUROPATHOGENESIS, AND HOST FACTORS
EARLY MACROPHAGE-INDEPENDENT INFLAMMATION AND SHIV-RNA IN CNS IN A RHESUS SHIV MODEL
Sandhya Vasan
Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CNS RESERVOIRS, NEUROPATHOGENESIS, AND HOST FACTORS
DEEP SEQUENCING REVEALS RARE CNS COMPARTMENTALIZATION IN ACUTE HIV-1 INFECTION
Rujipas Sirijatuphat
Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CNS RESERVOIRS, NEUROPATHOGENESIS, AND HOST FACTORS
CD4/CD8 RATIO ASSOCIATES WITH NEUROPSYCHOLOGIC PERFORMANCE DURING EARLY HIV INFECTION
Leah T Le
Yale University, New Haven, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CNS RESERVOIRS, NEUROPATHOGENESIS, AND HOST FACTORS
ASYMPTOMATIC HIV-1 CSF ESCAPE IS UNCOMMON AND IS NOT ASSOCIATED WITH NEURONAL DAMAGE
Sarah Beth Joseph
University of North Carolina, Chapel Hill, NC, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CNS RESERVOIRS, NEUROPATHOGENESIS, AND HOST FACTORS
GENETIC VARIATION IN EIF2AK3 IS ASSOCIATED WITH NEUROCOGNITIVE IMPAIRMENT IN HIV
Scott Letendre
University of California, San Diego, San Diego, CA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: CNS RESERVOIRS, NEUROPATHOGENESIS, AND HOST FACTORS
CEREBRAL SMALL-VESSEL DISEASE IN HIV-INFECTED PATIENTS WELL CONTROLLED ON CART
Dominique Costagliola
Sorbonne Universités, INSERM, UPMC Univ Paris 06, PARIS cedex 13, France
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: COMMON BEDFELLOWS: PREP, STIs, AND THE MICROBIOME
RESISTANCE EMERGENCE IN MACAQUES ADMINISTERED CABOTEGRAVIR LA DURING ACUTE INFECTION
Gerardo Garcia-Lerma
CDC, Atlanta , GA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: COMMON BEDFELLOWS: PREP, STIs, AND THE MICROBIOME
DAILY ORAL PREP IS EFFECTIVE AMONG WOMEN WITH ABNORMAL VAGINAL MICROBIOTA
Renee Heffron
University of Washington, Seattle, WA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: COMMON BEDFELLOWS: PREP, STIs, AND THE MICROBIOME
IMPACT OF VAGINAL MICROBIOTA ON GENITAL TISSUE AND PLASMA CONCENTRATIONS OF TENOFOVIR
Sharon L Hillier
University of Pittsburgh, Pittsburgh, PA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: COMMON BEDFELLOWS: PREP, STIs, AND THE MICROBIOME
ABUNDANCE OF PENILE ANAEROBES, IL-8, AND THE RISK OF HIV ACQUISITION, RAKAI, UGANDA
Lance Price
George Washington University, Washington, DC, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: COMMON BEDFELLOWS: PREP, STIs, AND THE MICROBIOME
DAPIVIRINE RING USE DOES NOT DIMINISH THE EFFECTIVENESS OF HORMONAL CONTRACEPTION
Jennifer Balkus
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: COMMON BEDFELLOWS: PREP, STIs, AND THE MICROBIOME
STD PARTNER SERVICES TO MONITOR AND PROMOTE PREP USE AMONG MEN WHO HAVE SEX WITH MEN
David A Katz
University of Washington, Seattle, WA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: COMMON BEDFELLOWS: PREP, STIs, AND THE MICROBIOME
CHALLENGES OF TRANSLATING PREP INTEREST INTO UPTAKE AMONG YOUNG BLACK MSM IN ATLANTA
Charlotte-Paige Melanie Rolle
Emory University School of Medicine, Atlanta, GA, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: COMMON BEDFELLOWS: PREP, STIs, AND THE MICROBIOME
ON DEMAND POST EXPOSURE PROPHYLAXIS WITH DOXYCYCLINE FOR MSM ENROLLED IN A PREP TRIAL
Jean-Michel Molina
Hôpital St Louis, Paris, France
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: ROLE OF HOST AND IMMUNE FACTORS IN HIV INFECTION
IMMUNE CORRELATES OF HIV ACQUISITION
Krystelle Nganou Makamdop
NIH, Bethesda, MD, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: ROLE OF HOST AND IMMUNE FACTORS IN HIV INFECTION
MARKED CHANGES IN CELLULAR BUT NOT VIRUS TRANSCRIPTOME IN CD4-LOW HIV-INFECTED CELLS
Joseph P Casazza
National Institutes of Health, USA, Bethesda, MD, USA
from CROI 2017 on February 15, 2017 10:00 AM-12:00 PM
<< first | < prev page: of 10 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 7 8 9 10 presentations: 1 to 50 of 454